alpha-amanitin and Colorectal Neoplasms

alpha-amanitin has been researched along with Colorectal Neoplasms in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ji, G; Li, YJ; Lu, XB; Van der Jeught, K; Xu, HC	1
Anderl, J; Ellis, LM; Han, C; He, X; Huang, X; Ivan, C; Jiang, D; Liu, Y; Lopez-Berestein, G; Lu, X; Maru, DM; Pahl, A; Rao, PH; Rodriguez-Aguayo, C; Sood, AK; Wan, G; Zhang, X	1

Reviews

1 review(s) available for alpha-amanitin and Colorectal Neoplasms

Article	Year
Drug resistance and new therapies in colorectal cancer. World journal of gastroenterology, 2018, Sep-14, Volume: 24, Issue:34 Topics: Alpha-Amanitin; Antineoplastic Agents, Immunological; Colorectal Neoplasms; Costimulatory and Inhibitory T-Cell Receptors; Drug Resistance, Neoplasm; Humans; Immunoconjugates; Immunotherapy; Microsatellite Instability; Nucleic Acid Synthesis Inhibitors; RNA Polymerase II; Treatment Outcome; Tumor Escape; Tumor Microenvironment; Tumor Suppressor Protein p53	2018

Article

Year

Drug resistance and new therapies in colorectal cancer.

World journal of gastroenterology, 2018, Sep-14, Volume: 24, Issue:34

Topics: Alpha-Amanitin; Antineoplastic Agents, Immunological; Colorectal Neoplasms; Costimulatory and Inhibitory T-Cell Receptors; Drug Resistance, Neoplasm; Humans; Immunoconjugates; Immunotherapy; Microsatellite Instability; Nucleic Acid Synthesis Inhibitors; RNA Polymerase II; Treatment Outcome; Tumor Escape; Tumor Microenvironment; Tumor Suppressor Protein p53

2018

Other Studies

1 other study(ies) available for alpha-amanitin and Colorectal Neoplasms

Article	Year
TP53 loss creates therapeutic vulnerability in colorectal cancer. Nature, 2015, Apr-30, Volume: 520, Issue:7549 Topics: Alpha-Amanitin; Animals; Antibodies; Antigens, Neoplasm; Catalytic Domain; Cell Adhesion Molecules; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Databases, Genetic; Disease Models, Animal; Epithelial Cell Adhesion Molecule; Female; Gene Deletion; Gene Dosage; Genes, p53; Humans; Immunoconjugates; Mice; Protein Subunits; RNA Polymerase II; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays	2015

Article

Year

TP53 loss creates therapeutic vulnerability in colorectal cancer.

Nature, 2015, Apr-30, Volume: 520, Issue:7549

Topics: Alpha-Amanitin; Animals; Antibodies; Antigens, Neoplasm; Catalytic Domain; Cell Adhesion Molecules; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Databases, Genetic; Disease Models, Animal; Epithelial Cell Adhesion Molecule; Female; Gene Deletion; Gene Dosage; Genes, p53; Humans; Immunoconjugates; Mice; Protein Subunits; RNA Polymerase II; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays

2015